http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2485449-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3f92d7abceacf6920355f265967d3b0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-064 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 2004-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_180e8c268025130b4f268bf93137ea1c |
| publicationDate | 2006-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2485449-A1 |
| titleOfInvention | Method for preventing mucositis during cancer therapy |
| abstract | The current invention describes a method for preventing and/or treating mucositis with a branched water soluble .beta.-1,3-glucan. Water soluble .beta.-glucan is used to prevent development of and/or promote healing of ulcers as exemplified by mouth and oropharynx ulcerations resulting from radio- and/or chemotherapy. The soluble .beta.-glucan can be applied directly to the potential affected mucosal areas as a solution, or mixture, or rinse, or gel, or mixed into any pharmaceutically acceptable carrier or vehicle. Other aspects of the invention are glucans for use in therapeutic compositions and uses of .beta.-glucan. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10166270-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765732-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3258948-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065287-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10232028-B2 |
| priorityDate | 2004-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.